NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054351

Registered date:01/06/2024

Prospective randomized controlled trial between lemborexant and benzodiazepine for pancreatobiliary patients with high risk factor of delirium

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedPancreatobiliary patents with high risk factor of delirium
Date of first enrollment2024/06/01
Target sample size90
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)benzodiazepine lemborexant

Outcome(s)

Primary OutcomeThe incidence rate of delirium
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximum99years-old
GenderMale and Female
Include criteria
Exclude criteria1 Undertaken antipsychotic drugs 2 Undertaken sleeping pills 3 Refusal to participate this study

Related Information

Contact

public contact
Name Takeshi Ogura
Address 2-7 Daigakuchou, Takatsukishi, Osaka Japan 569-8686
Telephone 072-683-1221
E-mail oguratakeshi0411@yahoo.co.jp
Affiliation Osaka Medical and Pharmaceutical University Hospital Endoscopy Center
scientific contact
Name Takeshi Ogura
Address 2-7 Daigakuchou, Takatsukishi, Osaka Japan
Telephone 072-683-1221
E-mail oguratakeshi0411@yahoo.co.jp
Affiliation Osaka Medical and Pharmaceutical University Hospital Endoscopy Center